1. Petito C. K., and Roberts, B. 1995: Evidence for apoptotic cell death in HIV encephalitis. Am. J. Fathol. 146:1121?1130.
2. Janssen, R. S., Nwanyanwu, O. C., Selik, R. M., and Stehr-Green, J. K. 1992. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 42:1472?1476.
3. Pascal, S., Resnick, L., Barker, W. W., Loewenstein, D., Yoshii, F., Chang, J., Boothe, T., Sheldon, J., and Duara, R. 1991. Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. J. Nucl. Med. 32: 1725?1729.
4. Brunetti, A., Berg, G., Di Chiro, G., Cohen, R. M., Yarchoan, R., Pizzo, P. A., Broder, S., Eddy, J., Fulham, M. J., Finn, R. D., and Larson, S. M. 1989. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3?-azido-2?,3?-dideoxythymidine (AZT, Zidovudine): a PET-FDG study. J. Nucl. Med. 30:581?590.
5. Pizzo, P. A., Eddy, J., Falloon, J., et al. 1988. Effect of continuous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N. Eng. J. Med. 319:889?896.